EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel tube Australia - engelsk - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel tube

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

EPIDUO FORTE adapalene/benzoyl peroxide 0.3%/2.5% gel bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

epiduo forte adapalene/benzoyl peroxide 0.3%/2.5% gel bottle

galderma australia pty ltd - adapalene, quantity: 3 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: docusate sodium; disodium edetate; poloxamer; propylene glycol; purified water; glycerol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris, when comedones, numerous papules and pustules are present in patients 12 years of age and older and the condition has not responded to first line treatment (see clinical trials).

EPIDUO 0.1%/2.5% adapalene / benzoyl peroxide gel bottle Australia - engelsk - Department of Health (Therapeutic Goods Administration)

epiduo 0.1%/2.5% adapalene / benzoyl peroxide gel bottle

galderma australia pty ltd - adapalene, quantity: 1 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: poloxamer; docusate sodium; purified water; glycerol; disodium edetate; propylene glycol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris on the face, chest and back when comedones, papules and pustules are present, and the condition has not responded to first line treatment.

EPIDUO adapalene / benzoyl peroxide 0.1%/2.5% gel tube Australia - engelsk - Department of Health (Therapeutic Goods Administration)

epiduo adapalene / benzoyl peroxide 0.1%/2.5% gel tube

galderma australia pty ltd - adapalene, quantity: 1 mg/g; benzoyl peroxide, quantity: 25 mg/g - gel - excipient ingredients: poloxamer; docusate sodium; purified water; glycerol; disodium edetate; propylene glycol; polysorbate 80; acrylamide/sodium acryloyldimethyltaurate copolymer; isohexadecane; sorbitan oleate - cutaneous treatment of acne vulgaris on the face, chest and back when comedones, papules and pustules are present, and the condition has not responded to first line treatment.

ADAPALENE AND BENZOYL PEROXIDE- adapalene and benzoyl peroxide gel USA - engelsk - NLM (National Library of Medicine)

adapalene and benzoyl peroxide- adapalene and benzoyl peroxide gel

actavis pharma, inc. - adapalene (unii: 1l4806j2qf) (adapalene - unii:1l4806j2qf), benzoyl peroxide (unii: w9wzn9a0gm) (benzoyl peroxide - unii:w9wzn9a0gm) - adapalene 1 mg in 1 g - adapalene and benzoyl peroxide gel 0.1% / 2.5% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. none teratogenic effects: pregnancy category c there are no well-controlled trials in pregnant women treated with adapalene and benzoyl peroxide gel. animal reproduction studies have not been conducted with the combination gel or benzoyl peroxide. furthermore, such studies are not always predictive of human response; therefore, adapalene and benzoyl peroxide gel should be used during pregnancy only if the potential benefit justifies the risk to the fetus. no teratogenic effects were observed in rats treated with oral doses of 0.15 to 5 mg adapalene/kg/day, up to 25 times (mg/m2 /day) the maximum recommended human dose (mrhd) of 2 grams of adapalene and benzoyl peroxide gel. however, teratogenic changes were observed in rats and rabbits when treated with oral doses of greater than or equal to 25 mg adapalene/kg/day representing 123 and 246 times mrhd, respectively. findin

TARO-ADAPALENE/BENZOYL PEROXIDE GEL Canada - engelsk - Health Canada

taro-adapalene/benzoyl peroxide gel

taro pharmaceuticals inc - adapalene; benzoyl peroxide - gel - 0.1%; 2.5% - adapalene 0.1%; benzoyl peroxide 2.5% - keratolytic agents

TARO-ADAPALENE/BENZOYL PEROXIDE FORTE GEL Canada - engelsk - Health Canada

taro-adapalene/benzoyl peroxide forte gel

taro pharmaceuticals inc - adapalene; benzoyl peroxide - gel - 0.3%; 2.5% - adapalene 0.3%; benzoyl peroxide 2.5% - keratolytic agents

ADAPALENE+BENZOYL PEROXIDE/LABORATOIRES MEDGEN GEL (1+25)MG/G Hellas - gresk - Εθνικός Οργανισμός Φαρμάκων

adapalene+benzoyl peroxide/laboratoires medgen gel (1+25)mg/g

laboratoires medgen, france 24 rue erlanger, 75016 paris - adapalene; benzoyl peroxide hydrous - gel (ΓΕΛΗ) - (1+25)mg/g - adapalene 1mg; benzoyl peroxide hydrous 34,01mg - adapalene, combinations

Adapalene/Benzoyl peroxide Orifarm 1 mg / g + 25 mg / g geeli Finland - finsk - Fimea (Suomen lääkevirasto)

adapalene/benzoyl peroxide orifarm 1 mg / g + 25 mg / g geeli

orifarm healthcare a/s - benzoyl peroxide, hydrous, adapalene - geeli - 1 mg / g + 25 mg / g - adapaleeni

SANDOZ ADAPALENE / BENZOYL PEROXIDE FORTE GEL Canada - engelsk - Health Canada

sandoz adapalene / benzoyl peroxide forte gel

sandoz canada incorporated - adapalene; benzoyl peroxide - gel - 0.3%; 2.5% - adapalene 0.3%; benzoyl peroxide 2.5% - keratolytic agents